fig3

Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance

Figure 3. Schematic representation of TCS/ABZ-BSA/Ag NPs internalization utilizing SPARC-mediated endocytosis, as well as antitumor mechanisms against A549/T cells[51]

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/